Roman Orsini, DPM
Foot & Ankle Surgery · Lewes, DENPI 1184721664
Payments from drug & device makers
What this record shows
Stryker accounts for 66.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,532 and has fallen 87.1% since, to $328 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in DE, where the typical reported total is $3,171.
Across 38 payments — averaging $83.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Supreme Orthopedic Systems, LLC$731
- Smith+Nephew$143
- AstraZeneca$125
- Pacira Therapeutics, Inc.$55
- Acacia Pharma Inc$25
What the payments were for
- Travel & lodging$1,46946%
- Food & beverage$1,70254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 27 | $2,092 |
| Supreme Orthopedic Systems, LLC | 7 | $731 |
| Smith+Nephew | 1 | $143 |
| AstraZeneca | 1 | $125 |
| Pacira Therapeutics, Inc. | 1 | $55 |
| Acacia Pharma Inc | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$906
- INBONE$309
- VARIAX$267
- EASYFUSE$162
- INFINITY ADAPTIS$162
- EVOS$143
- TRIGEN InterTAN$143
- LOKELMA$125
- ANCHORAGE$106
- SONICFUSION$106
How this compares
$3,171 in reported general payments places this provider in the 50th percentile of 32 foot & ankle surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $13,063 |
| Gabapentin | 132 | $1,407 |
| Pregabalin | 87 | $1,268 |
| Terbinafine Hcl | 76 | $781 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 102 | $702 |
| Meloxicam | 140 | $601 |
| Doxycycline Hyclate | 44 | $545 |
| Prednisone | 27 | $260 |
| Naproxen | 22 | $225 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $195 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $126 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lewes
- Brendan KaneLewes$11K
- Johanna LightcapLewes$4K
- Claire CapobiancoLewes$55
- Jacob HanlonDover$50K
- Cody BowersWilmington$14K
- Bradley LemonSeaford$10K
- Kirstyn UrbasNewark$7K
- Korey DuboisWilmington$7K
- Katrin HeinemanWilmington$6K
- Katherine PersckyWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.